Form 4: Conduit Pharmaceuticals Director Acquires Shares in Lieu of Cash Retainer

Director Freda Lewis-Hall acquired 437,976 shares of Conduit Pharmaceuticals stock in lieu of a cash retainer, while also holding indirect ownership of additional shares through Intelmed LLC and her spouse.

Summary

• Freda Lewis-Hall, a director at Conduit Pharmaceuticals, acquired 437,976 shares of common stock on November 18, 2024.
• These shares were issued in lieu of a $40,250 cash retainer under the company's Non-Employee Director Compensation Program.
• The shares were acquired at a price of $0.0919 per share.
• Ms. Lewis-Hall also has indirect beneficial ownership of 2,003,324 shares through Intelmed LLC, where she is the Managing Director.
• Additionally, she may be deemed to share beneficial ownership of 516,987 shares held by her spouse, Mr. Emerson Hall, Jr.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction of a director receiving shares, which is generally positive as it aligns interests with shareholders. There are no negative implications.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.
• The use of shares in lieu of cash preserves company cash reserves.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders who have transactions in their company's stock. It provides transparency into the ownership changes of company directors.

Comparison to Industry Standards

• The use of stock in lieu of cash compensation is a common practice among publicly traded companies, especially for non-employee directors.
• The reporting of beneficial ownership through related entities and family members is also standard practice and is required by SEC regulations.
• The transaction is similar to other director compensation programs in the pharmaceutical industry, where equity is often used to align director interests with shareholder value.

Stakeholder Impact

• The share acquisition by a director may be viewed positively by shareholders as it demonstrates confidence in the company's future.
• The use of shares instead of cash may be seen as a positive for the company's financial health.

Key Dates

Keywords

Conduit Pharmaceuticals, Director, Share Acquisition, Beneficial Ownership, Stock, Non-Employee Director Compensation, Intelmed LLC